JLP-1901
/ Jeil
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
December 15, 2023
To Evaluate the Safety and Pharmacokinetic Characteristics After the Administration of JC-001 and JLP-1901
(clinicaltrials.gov)
- P1 | N=48 | Completed | Sponsor: Jeil Pharmaceutical Co., Ltd.
New P1 trial
1 to 1
Of
1
Go to page
1